MLchartDataset catalogue

ESA

Term · Oncology and biomedicine · MLC-T-ONC-002974

A substance that stimulates the bone marrow to make more red blood cells. ESAs are used to treat anemia caused by chronic kidney failure, some anticancer drugs, and certain treatments for HIV. They may also be used to lower the number of blood transfusions needed during and after certain major surgeries. Examples of ESAs are epoetin alfa (Epogen, Procrit) and darbepoetin alfa (Aranesp). Also called erythropoiesis-stimulating agent.

Table 1. Record
IdentifierMLC-T-ONC-002974
FieldOncology and biomedicine
Expansionserythropoiesis-stimulating agent
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-002974",
  "term": "ESA",
  "field": "Oncology and biomedicine",
  "definition": "A substance that stimulates the bone marrow to make more red blood cells. ESAs are used to treat anemia caused by chronic kidney failure, some anticancer drugs, and certain treatments for HIV. They may also be used to lower the number of blood transfusions needed during and after certain major surgeries. Examples of ESAs are epoetin alfa (Epogen, Procrit) and darbepoetin alfa (Aranesp). Also called erythropoiesis-stimulating agent.",
  "expansions": [
    "erythropoiesis-stimulating agent"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/esa/"
}

Record 6,893 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.